Recruiting

Genomic & Proteomic

Sponsor:

University of Pittsburgh

Code:

NCT00373841

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.

Conditions

Idiopathic Pulmonary Fibrosis

Study ID

NCT00373841

Start date

Oct, 2005

Status verified date

Aug, 2026

Completion date

Jul, 2030

Anticipated

Primary completion date

Jul, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who are 18 or older
  • Diagnosis of Idiopathic Pulmonary Fibrosis
  • Treated at the Simmons Center

Exclusion Criteria:

  • Other Lung Illness

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Michelle MacPherson, MAT

412-647-4537macphersonmj@upmc.edu

Michelle Meyers, BSN RN

412-692-2149meyersma@upmc.edu

Locations

Michelle F MacPherson

Recruiting

Pittsburgh, Pennsylvania, United States, 15213

Contacts

Michelle F MacPherson, MAT

14126474537macphersonmj@upmc.edu

Michelle L Meyers, BSN RN

412-692-2149meyersma@upmc.edu

Principal Investigator:

Kevin F Gibson, MD

More Information

Sponsor

University of Pittsburgh

Last update posted

Aug 27, 2026

Last verified

Aug, 2026

Keywords

  • Lung
  • Fibrosis
  • Idiopathic
  • Biomarkers
  • Genomics
  • Longitudinal

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Pittsburgh on 2026-08-27.